Laboratories. Chloroquine and pepstatin A were purchased from Sigma-Aldrich. E64d was purchased from Santa Cruz Biotechnology.
GFP-LC3 punctae formation assay
HeLa cells stably expressing eGFP-LC3 were plated in 384-well plates (Corning, 3712) at 2,500 cells per well in 50 µL of IMDM. The following day, 100 nL of compounds were pin-transferred into plates using a CyBi-Well Vario (CyBiO) and incubated with cells for 4 hr at 37C. Cells were then fixed in 3.7% paraformaldehyde (PFA) for 15 minutes at room temperature, washed, and DNA stained with 2 μg/mL Hoechst 33342 (Sigma B2261). High-throughput imaging at 20X was performed on an ImageXpress Micro automated microscope (Molecular Devices) using the DAPI and GFP filters. Four sites were imaged for each well with about 250-300 cells/site. The number of GFP punctae per cell was quantified using the MetaXpress high-content image analysis software (Transfluor module).
For the primary screen, significant differences were assessed by computing an empirical test statistic, termed prevalence, which compares the observed distribution of punctae per cell in compoundtreated cells (test hypothesis) to that of DMSO-treated cells (null hypothesis). Specifically, it is computed as the area under the curve of the test distribution beyond the critical value corresponding to 95% confidence of the null distribution. Prevalence is useful for assessing significance when comparing two populations that do not follow a normal distribution pattern, which is the case for punctae per cell in the GFP-LC3 assay. The concentration of the positive control (5 μM PI-103) was selected through dose-response studies identifying the lowest concentration in the range at which PI-103 reproducibly demonstrates maximal activity (typically 5-20 μM) without apparent significant toxicity (Supporting Information Figure S1A and data not shown). Plates in which 5 μM PI-103 induced a prevalence score ≥ 0.5 were considered well performing and included for further analysis.
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Z' scores were calculated for overall assay performance using prevalence scores from 32 wells of negative control (DMSO) and 32 wells of positive control (PI-103) on each plate and were typically between 0.6-0.8 for all plates screened.
To quantify the effect of hit compounds on autophagosome number in dose-response ( Figure 1 ), we computed the average number of GFP punctae per cell following compound treatment (2 wells per dose point), and subtracted the average number observed for DMSO-treated cells (16 wells). These values were normalized to the background-subtracted average number of punctae per cell observed for the positive control 20 μM PI-103 (16 wells), and plotted in Figure 1 .
mCherry-eGFP-LC3 assay
HeLa cells stably expressing mCherry-eGFP-tagged LC3 were seeded overnight in 384-well plates (Corning, 3712) at 2,000 cells per well in 50 µL of IMDM. Compounds along with in-plate controls (PI-103, chloroquine, and bafilomycin A1) were pin-transferred into plates and incubated at 37C for 24 hours. Cells were then fixed in 3.7% paraformaldehyde (PFA) for 15 minutes at room temperature, washed, and DNA stained with 2 μg/mL Hoechst 33342 (Sigma B2261). High-throughput imaging at 20X was performed on an ImageXpress Micro automated microscope (Molecular Devices) using the DAPI, Texas Red, and GFP filters. Four sites were imaged for each well with about 250-300 cells/site. The numbers of GFP+ and mCherry+ punctae per cell were quantified using the MetaXpress highcontent image analysis software (Transfluor module).
Immunoblotting
Cells were washed with phosphate buffered saline (PBS) and lysed for 30 minutes on ice in the lysis buffer (100 mM Tris-HCl (pH=7.6), 100 mM NaCl, 1% NP-40, and Complete Mini protease inhibitor cocktail (Roche)). Following SDS-PAGE (Mini-PROTEAN TGX Any kD gels, Bio-Rad), proteins were transferred onto PVDF membranes (Immobilon-FL, Millipore) and blocked in the Odyssey blocking buffer (LI-COR P/N 927) for 1 hour at room temperature. Membranes were subjected to overnight primary antibody incubation at 4C and 1 hour secondary antibody incubation at room temperature, and subsequently imaged on the LI-COR infrared imaging system. The following antibodies were used: 1:1,000 α-LC3B (L7543), 1:5,000 α-actin (A1978), from Sigma, and 1:20,000 IRDye 680LT Goat α-Rabbit IgG(H+L) (P/N 926-68021) and 1:5,000 IRDye 800CW Goat α-mouse IgG(H+L) (P/N 926-32210) from LI-COR Biosciences.
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LysoTracker displacement assay
HeLa cells were seeded overnight in 384-well plates (Corning, 3712) at 2,500 cells per well in 50 µL of IMDM. The following day, compounds were pin-transferred into plates and incubated at 37ºC for 4 hours. Subsequently, 10 μL of IMDM containing LysoTracker Red dye (Life Technologies, L7528) and
Hoechst 33342 was added to bring the LysoTracker dye and Hoechst 33342 to final concentrations of 100 nM and 2 μg/mL, respectively. After staining for 1 hour, the media in each well was replaced with PBS and the plate was immediately imaged on an ImageXpress Micro automated microscope using the DAPI and Texas Red filters. Four sites were imaged for each well with about 200-250 cells/site. MetaXpress (Transfluor module) was used to quantify the number of LysoTracker punctae per cell and average intensity of LysoTracker Red per cell.
DQ-BSA assay
HeLa cells were seeded overnight in 384-well plates (Corning, 3712) at 2,500 cells per well in 50 µL of IMDM. The following day, the media was replaced with 50 µL of IMDM containing 10 μg/mL DQ-BSA Red dye (Life Technologies, D12051), and the cells were incubated at 37ºC for 1 hour. The media was aspirated, the cells were washed with IMDM, and fresh IMDM was added. Compounds were pin-transferred into plates and incubated at 37ºC for 6 hours. During the final 1 hour, 10 μL of IMDM containing Hoechst 33342 (final concentration of 2 μg/mL) was added. After staining for 1 hour, the media in each well was replaced with PBS and the plate was immediately imaged on an ImageXpress Micro automated microscope using the DAPI and Texas Red filters. Four sites were imaged for each well with about 200-250 cells/site. MetaXpress (Transfluor module) was used to quantify the number of DQ-BSA Red punctae per cell.
Sensitivity profiling of 83 cancer cell lines
Cancer cell-line sensitivity data were gathered as previously described. 1, 2 Briefly, cells were plated at 500 cells/well in 1536-well plates, allowed to adhere overnight, and treated for 72 hours with each compound at 16 different concentrations. ATP levels were measured using CellTiterGlo (Promega) as a measure of viability, and the area under the dose response curve (AUC) was determined as a metric for sensitivity. To identify compounds having similar activity as BRD1240, we computed correlation coefficients between the profiles of sensitivity measurements gathered for BRD1240 and each of 480 compounds. Spearman correlation was initially selected over Pearson correlation since it is less affected by single (or a few) extreme outlier cell line measurements and better equipped to S5 capture the correlation across the whole cell line collection. Similar results were obtained with Pearson correlations (data not shown).
In vitro V-ATPase activity assay
This assay was performed as previously described. 3 Briefly, HEK293 cells from a confluent 15-cm dish were incubated overnight with 35 μg/mL Dx-OG514 (Life Technologies D-7176). The following day, cells were washed with PBS once and incubated with serum-free DMEM for 2 hours. 15 minutes prior to lysis, FCCP (Sigma) was added into the medium to a final concentration of 1 μM. Cells were scraped, pelleted and resuspended in 750 μL fractionation buffer (50 mM KCl, 90 mM K-Gluconate, 1 mM EGTA, 50 mM Sucrose, 5 mM Glucose, 20 mM HEPES (all from Sigma), Complete Mini protease inhibitor cocktail (Roche), pH=7.4) supplemented with 1 μM FCCP. Cells were broken by spraying for 7-10 times through a 25G needle, and subsequently spun down at 10,000 rpm for 15 seconds at 4ºC. Afterward, the supernatant was collected and centrifuged at max speed for 20 minutes, yielding a pellet containing the organelle fraction. The pellet was resuspended in pre-warmed fractionation buffer supplemented with 1% BSA (Sigma), split into 12 aliquots, and transferred into a black 96-well plate (Corning, 3904). If compound pretreatment was applied, membranes were incubated with compounds at 37ºC for 1 hour. Baseline fluorescence was measured at 530 nm upon 511 nm excitation in a Synergy H4 microplate reader (BioTek) at 30-second intervals for 5 minutes. To activate the V-ATPase, 5 mM ATP (Sigma, A1852) and 5 mM MgCl 2 were introduced to each well, and fluorescence reading was continued for another 25 minutes. Active V-ATPases caused lysosomal reacidification and therefore caused a decrease in fluorescence emission of OG-514 over time. At the end of the measurement, 1 μg/mL nigericin (Sigma) was added to each well to ensure the observation of rapid dissipation of the lysosomal proton gradient.
Statistical analysis
Dose-response curves and EC 50 values from the GFP-LC3 punctae formation assay were generated using the least squares fit function (four parameters), with the constraint that "top value" had to be larger than 100, in Prism 6 software (GraphPad). Spearman correlation coefficients computed to identify compounds having similar activity as BRD1240 against 83 cancer cell lines were determined using MATLAB R2013b (MathWorks). was added at room temperature, followed by tert-butyldimethylsilyl trifluoromethanesulfonate (9 μL, 0.048 mmol). The mixture was stirred until complete consumption of starting material was observed by TLC (2 hr). The reaction was quenched with sat. NaHCO 3 solution and extracted with DCM (2x).
The combined organic extracts were dried over sodium sulfate, filtered, and concentrated. The 45, 144.11, 143.89, 141.38, 141.33, 132.90, 130.87, 127.70, 127.66, 127.09, 127.04, 126.83, 126.49, 124.97, 119.96, 84.50, 67.94, 67.37, 64.33, 60.35, 55.89, 52.36, 49.96, 47.36, 36.91, 34.57, 30.66, 25.86, 25.81, 20.98, 19.12, 18.18, 15.52, 15.34, 14.19, 13.68, -5.48, -5.50 . LCMS (M+H) + = 743.2, 745.2 TBS ether 2 (23 mg, 0.031 mmol) was suspended in DMF (0.64 mL) in a flame-dried 4 mL glass vial, and piperidine (0.16 mL) was added at room temperature. The reaction was stirred until complete consumption of starting material was observed by TLC (0.5 hr). Saturated NH 4 Cl was added and the mixture extracted with ethyl acetate (3x), dried over sodium sulfate, and condensed to give the crude amine, which was purified by flash chromatography (Isco, silica 4 g, 0-35% MeOH in DCM, 20 min) to give the amine as a colorless oil (15.5 mg, 95%). This amine (15.5 mg, 0.030 mmol) was suspended in dichloromethane (1.2 mL, 0. 54, 156.19, 147.78, 143.83, 133.60, 133.00, 130.50, 127.08, 126.99, 126.34, 113.81, 107.89, 103.80, 101.11, 85.92, 67.37, 56.97, 52.21, 50.20, 37.25, 34.90, 25.86, 25.80, 18.18, 15.78, 15.38, -5.48 . LCMS (M+H) + = 684.1, 686.1 Urea 3 (18.0 mg, 0.026 mmol) was suspended in DMF (1.55 mL, 0.017 M) and Et 3 N (0.88 mL, 6.31 mmol) in a flame-dried 4 mL glass vial. 4-ethynylpyridine (8.13 mg, 0.079 mmol) was added and the resulting solution stirred for 10 min at 25 °C. Pd(PPh 3 )Cl 2 (4.6 mg, 6.57 μmol) was added, followed by CuI (5.0 mg, 0.026 mmol). The reaction vessel was purged and filled with N 2 (2x) and was then heated to 60 °C for 36 hr. The reaction was cooled to room temperature, quenched by addition of sat. NH 4 Cl, extracted with ethyl acetate, dried over sodium sulfate, and condensed in vacuo. The crude product was purified by flash chromatography (Isco, silica 4 g, EtOAc in hexanes, 0-50% over 15 min, 50% hold 5 min, then 50-95% over 10 min, hold 2 min at 95%) to give the desired product as a pale yellow solid (14 mg, 75%). This product was suspended in THF (1.0 mL, 0.02 M) in a flame-dried 4 S9 mL glass vial, cooled to 0 o C, and TBAF (0.04 mL, 0.040 mmol, 1.0 M in THF) was added dropwise.
The resulting solution was warmed to room temperature and stirred until complete consumption of starting material was observed by TLC and LCMS (1 hr). The reaction was quenched with NaHCO 3 and extracted with ethyl acetate (3x). The combined organic extracts were dried over sodium sulfate, filtered, and concentrated. The resulting crude product was purified by flash chromatography (Isco, silica 4 g, 0-10% MeOH in DCM, 28 min) to provide BRD1240 as a pale yellow solid (9.2 mg, 79%). 40, 156.08, 148.55, 147.48, 143.67, 134.85, 133.57, 131.62, 129.56, 127.22, 126.62, 126.27, 125.96, 114.49, 107.27, 103.99, 100.92, 88.28, 84.91, 66.44, 64.87, 56.38, 51.67, 49.25, 37.01, 33.56, 22.92, 14.42, 14.19 . LCMS 
